Article
Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jul 2012
Livnat Tami, Shenkman Boris, Spectre Galia, Tamarin Ilia, Dardik Rima, Israeli Amnon, Rivkind Avraham, Shabtai Moshe, Marinowitz Uri, Salomon Ophira
Abstract excerpt
Factor VII deficiency is the most common among the rare autosomal recessive coagulation disorders worldwide. In factor VII deficient patients, the severity and clinical manifestations cannot be reliably determined by factor VII levels. Severe bleeding tends to occur in individuals with factor VII activity levels of 2% or less of normal. Patients with 2-10% factor VII vary between asymptomatic to severe life...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.